Cathie Wood's $362 Million CRISPR Bet: Hidden Catalyst
Cathie Wood’s big bet on CRISPR Therapeutics signals more than faith in gene editing. This article digs into the unde...
Understand portfolio volatility for bonds versus index funds in retirement and how it affects withdrawal strategies and peace of mind.
23,614 articlesCathie Wood’s big bet on CRISPR Therapeutics signals more than faith in gene editing. This article digs into the unde...
Pi Network pushed through a February deadline with few updates, fueling community scrutiny while markets react. This ...
A dramatic drop can set the stage for a smart rebound. This guide explains how to analyze a growth stock down right, ...
Two tech names, two very different stories. This guide breaks down Palantir and Microsoft to answer a simple question...
President Donald Trump announces a sweeping 10% global tariff on imports, seeking to salvage a faltering trade agenda...
As Home Depot gears up to report, investors weigh EPS targets, margin dynamics, and housing trends. This guide breaks...
AI fears roiled tech names, dragging CrowdStrike lower despite strong fundamentals. Analysts see a 40% upside as sent...
Quantum hype is everywhere, but one cloud leader is turning theory into revenue today. This article explains how they...
As 2025 closes, star bulk (sblk) enters a new chapter. This guide breaks down the Q4 2025 results, fleet strategy, ba...
MercadoLibre faced a sharp price move after a quarter that showed strong top-line momentum but weaker profitability. ...
A biotech insider trade draws attention after an FDA setback. This article unpacks the CFO's $720k stock sale at Disc...
A drone maker sparked a quick rally before giving up gains as contract news hit. This piece breaks down why aeroviron...